Home

overview

Join Drs Sabari and Spira for this live webinar focused on new data on EGFR- and KRAS-targeted therapies for advanced NSCLC from the annual oncology meeting in Chicago. Our expert faculty will discuss the latest information and any potential clinical implications, with the ultimate goal of improving patient outcomes. You don’t want to miss this exciting event!

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

FACULTY

Joshua Sabari, MD

Assistant Professor of Medicine

NYU Grossman School of Medicine

Thoracic Medical Oncologist

NYU Langone Health Perlmutter Cancer Center

New York, New York

FACULTY

Alexander Spira, MD, PhD, FACP

Medical Oncologist

Co-Director, Virginia Cancer Specialists Research Institute

Clinical Director, NEXT Oncology

Fairfax, Virginia

Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video encouraged*

TARGET AUDIENCE

This educational activity is intended for an audience of oncologists, pathologists, pulmonologists, surgeons, nurse practitioners, physician assistants, nurses, pharmacists, and other members of the NSCLC care team in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to understand the clinical impact of the latest data on targeted therapies for NSCLC care.

LEARNING OBJECTIVES

Upon completion of this activity, participants will:

Have increased knowledge regarding the:

Evolving data on targeted treatment strategies for patients with NSCLC

Have greater competence related to:

Crafting custom care plans to address the needs of patients with NSCLC

Demonstrate greater confidence in their ability to:

Translate the latest findings into effective clinical strategies for NSCLC care

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

New Directions in NSCLC Care CME